Where do MSCs come from? Tissue sources and autologous versus allogeneic cells
MSCs can be sourced from several tissues, from the patient or from a donor. The source and the processing shape both the product and how it is regulated.

Key takeaways.
- MSC sources include bone marrow, adipose tissue, umbilical cord blood and tissue, dental pulp and placenta.
- Adipose tissue yields the most MSCs per gram, roughly 100 to 500 times more than bone marrow.
- Harvest, isolation and expansion each affect what cells are recovered and how they behave.
- The autologous or allogeneic choice shapes the regulatory pathway and manufacturing logistics.
- Culture-expanding MSCs moves most products into the FDA's Section 351 biological drug category.
Tissue sources
Mesenchymal stem/stromal cells (MSCs) have been sourced from several tissues. These include bone marrow, adipose tissue, umbilical cord blood, umbilical cord tissue (Wharton's Jelly), dental pulp, peripheral blood and placental tissue.
Yield differs by source. Adipose tissue, obtained through liposuction, yields the highest number of MSCs per gram of tissue. The course puts this at approximately 100 to 500 times more than bone marrow.
Processing changes the product
Each step from tissue to product affects the cells. How tissue is harvested affects what is recovered. Isolation methods determine purity and yield. Expansion conditions influence cell properties.
Storage matters too. Frozen cell products use DMSO (dimethyl sulfoxide) as a cryoprotectant. It prevents the formation of ice crystals, which can damage cell membranes during freezing.
Autologous versus allogeneic
Autologous cells come from the patient who will receive them. Allogeneic cells come from a donor. The course describes this choice as shaping everything from regulatory pathway to manufacturing logistics.
How source and processing meet regulation
The FDA treats culture expansion of MSCs as more than minimal manipulation. That places most expanded MSC products in the Section 351 category, which is regulated as a biological drug. There is a narrow exception for autologous cells removed and reimplanted during the same surgical procedure.
Stem cell therapies are not FDA-approved for the orthopaedic, pain and aesthetic uses that clinics market. The tissue source does not change that.
Educational content for healthcare professionals. Not a treatment recommendation. Stem cell therapies are not FDA-approved for the orthopaedic, pain and aesthetic uses most clinics offer.
This guide covers the what and the why.
The how is taught live. The webinar and live training go deeper on:
- Harvest and isolation methods
- Expansion conditions and their effect on cells
- How the main tissue sources compare in practice
- Regulatory consequences of each sourcing choice
Common questions.
Which tissue yields the most MSCs?
What is the difference between autologous and allogeneic cells?
Why is DMSO used when freezing cells?
Sources
- Matas J, Orrego M, Amenabar D, Infante C, Tapia-Limonchi R, Cadiz MI, et al. Umbilical cord-derived mesenchymal stromal cells (MSCs) for knee osteoarthritis: A randomized double-blind placebo-controlled clinical trial. Stem Cells Transl Med. 2019;8(6):504-13.
- Pers YM, Rackwitz L, Ferreira R, Pullig O, Delfour C, Barry F, et al. Adipose mesenchymal stromal cell-based therapy for severe osteoarthritis of the knee: A phase I dose-escalation trial. Stem Cells Transl Med. 2016;5(7):847-56.
- Ullah I, Subbarao RB, Rho GJ. Human mesenchymal stem cells - current trends and future prospective. Biosci Rep. 2015;35(2):e00191.
Keep reading.
Stem cell · 3 min read
How are stem cell products quality-checked?
Cell products are checked for identity, contamination and genetic stability. This guide explains the main tests and what each one is for.
Start the lessonStem cell · 3 min read
How does the FDA regulate stem cell products? Section 361 versus Section 351
The FDA sorts cell and tissue products into two categories, Section 361 and Section 351. Culture expansion usually puts an MSC product in the stricter one.
Start the lessonStem cell · 3 min read
How do published stem cell studies select patients?
Who is enrolled shapes what a stem cell study can show. This guide covers how published MSC research frames disease stage, phenotype and tissue type.
Start the lessonReady for the hands-on detail?
Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.